tecfidera gastro-resistant hard capsules 120 mg
eisai (singapore) pte. ltd. - dimethyl fumarate - capsule, enteric coated - dimethyl fumarate 120.0mg
tecfidera gastro-resistant hard capsules 240 mg
eisai (singapore) pte. ltd. - dimethyl fumarate - capsule, enteric coated - dimethyl fumarate 240.0 mg
fingolimod teva 0.5 mg hard capsules
teva b.v. - fingolimod - capsule, hard - 0.5 milligram(s) - fingolimod
fingolimod teva 0.5 mg hard capsules
norton waterford - fingolimod - capsule, hard - 0.5 milligram(s) - fingolimod
apo-dimethyl fumarate dimethyl fumarate 240 mg enteric coated capsule blister pack
arrotex pharmaceuticals pty ltd - dimethyl fumarate, quantity: 240 mg - capsule, enteric - excipient ingredients: croscarmellose sodium; gelatin; purified talc; magnesium stearate; iron oxide yellow; silicified microcrystalline cellulose; triethyl citrate; titanium dioxide; brilliant blue fcf; methacrylic acid copolymer; colloidal anhydrous silica; iron oxide black; methacrylic acid - ethyl acrylate copolymer (1:1); propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - dimethyl fumarate enteric coated capsules are indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.
apo-dimethyl fumarate dimethyl fumarate 120 mg enteric coated capsule blister pack
arrotex pharmaceuticals pty ltd - dimethyl fumarate, quantity: 120 mg - capsule, enteric - excipient ingredients: croscarmellose sodium; gelatin; purified talc; magnesium stearate; iron oxide yellow; silicified microcrystalline cellulose; triethyl citrate; titanium dioxide; brilliant blue fcf; methacrylic acid copolymer; colloidal anhydrous silica; iron oxide black; methacrylic acid - ethyl acrylate copolymer (1:1); propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - dimethyl fumarate enteric coated capsules are indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.
fingolimod 0.5 mg hard capsules
rowa pharmaceuticals limited - fingolimod - capsule, hard - 0.5 milligram(s) - fingolimod
fingolimod tiefenbacher 0.5 mg hard capsules
alfred e tiefenbacher (gmbh & co. kg) - fingolimod - capsule, hard - 0.5 milligram(s) - fingolimod
fingolimod clonmel 0.5 mg hard capsules
clonmel healthcare ltd - fingolimod - capsule, hard - 0.5 milligram(s) - fingolimod
fingolimod tillomed 0.5 mg hard capsules
tillomed pharma gmbh - fingolimod - capsule, hard - 0.5 milligram(s) - fingolimod